These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37449573)

  • 1. Splanchnic Nerve Modulation Effects on Surrogate Measures of Venous Capacitance.
    Kittipibul V; Ganesh A; Coburn A; Coyne BJ; Gray JM; Molinger J; Ray N; Podgoreanu M; McCartney SL; Mamoun N; Fitzhugh RC; Lurz P; Green CL; Hernandez AF; Patel MR; Fudim M
    J Am Heart Assoc; 2023 Jul; 12(14):e028780. PubMed ID: 37449573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splanchnic Nerve Block for Chronic Heart Failure.
    Fudim M; Boortz-Marx RL; Ganesh A; DeVore AD; Patel CB; Rogers JG; Coburn A; Johnson I; Paul A; Coyne BJ; Rao SV; Gutierrez JA; Kiefer TL; Kong DF; Green CL; Jones WS; Felker GM; Hernandez AF; Patel MR
    JACC Heart Fail; 2020 Sep; 8(9):742-752. PubMed ID: 32535123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splanchnic Nerve Block Mediated Changes in Stressed Blood Volume in Heart Failure.
    Fudim M; Patel MR; Boortz-Marx R; Borlaug BA; DeVore AD; Ganesh A; Green CL; Lopes RD; Mentz RJ; Patel CB; Rogers JG; Felker GM; Hernandez AF; Sunagawa K; Burkhoff D
    JACC Heart Fail; 2021 Apr; 9(4):293-300. PubMed ID: 33714749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Preload in Heart Failure: Splanchnic Nerve Blockade and Beyond.
    Fudim M; Khan MS; Paracha AA; Sunagawa K; Burkhoff D
    Circ Heart Fail; 2022 Mar; 15(3):e009340. PubMed ID: 35290092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splanchnic nerve modulation in heart failure: mechanistic overview, initial clinical experience, and safety considerations.
    Fudim M; Ponikowski PP; Burkhoff D; Dunlap ME; Sobotka PA; Molinger J; Patel MR; Felker GM; Hernandez AF; Litwin SE; Borlaug BA; Bapna A; Sievert H; Reddy VY; Engelman ZJ; Shah SJ
    Eur J Heart Fail; 2021 Jul; 23(7):1076-1084. PubMed ID: 33886137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
    Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
    Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise Stress Real-Time Cardiac Magnetic Resonance Imaging for Noninvasive Characterization of Heart Failure With Preserved Ejection Fraction: The HFpEF-Stress Trial.
    Backhaus SJ; Lange T; George EF; Hellenkamp K; Gertz RJ; Billing M; Wachter R; Steinmetz M; Kutty S; Raaz U; Lotz J; Friede T; Uecker M; Hasenfuß G; Seidler T; Schuster A
    Circulation; 2021 Apr; 143(15):1484-1498. PubMed ID: 33472397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Baseline Hemodynamics on the Effects of a Transcatheter Interatrial Shunt Device in Heart Failure With Preserved Ejection Fraction.
    Wessler J; Kaye D; Gustafsson F; Petrie MC; Hasenfuβ G; Lam CSP; Borlaug BA; Komtebedde J; Feldman T; Shah SJ; Burkhoff D;
    Circ Heart Fail; 2018 Aug; 11(8):e004540. PubMed ID: 30354556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical ablation of the right greater splanchnic nerve for the treatment of heart failure with preserved ejection fraction: first-in-human clinical trial.
    Málek F; Gajewski P; Zymliński R; Janczak D; Chabowski M; Fudim M; Martinca T; Neužil P; Biegus J; Mates M; Krüger A; Skalský I; Bapna A; Engelman ZJ; Ponikowski PP
    Eur J Heart Fail; 2021 Jul; 23(7):1134-1143. PubMed ID: 33932262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splanchnic venous pressure-volume relation during experimental acute ischemic heart failure. Differential effects of hydralazine, enalaprilat, and nitroglycerin.
    Wang SY; Manyari DE; Scott-Douglas N; Smiseth OA; Smith ER; Tyberg JV
    Circulation; 1995 Feb; 91(4):1205-12. PubMed ID: 7850960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversing the Cardiac Effects of Sedentary Aging in Middle Age-A Randomized Controlled Trial: Implications For Heart Failure Prevention.
    Howden EJ; Sarma S; Lawley JS; Opondo M; Cornwell W; Stoller D; Urey MA; Adams-Huet B; Levine BD
    Circulation; 2018 Apr; 137(15):1549-1560. PubMed ID: 29311053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of splanchnic circulation in the pathogenesis of heart failure: State-of-the-art review.
    Yaku H; Fudim M; Shah SJ
    J Cardiol; 2024 May; 83(5):330-337. PubMed ID: 38369183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
    Mohammed SF; Borlaug BA; McNulty S; Lewis GD; Lin G; Zakeri R; Semigran MJ; LeWinter M; Hernandez AF; Braunwald E; Redfield MM
    Circ Heart Fail; 2014 Jul; 7(4):580-9. PubMed ID: 24833648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE).
    St John Sutton M; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B
    J Am Heart Assoc; 2015 Sep; 4(9):e002054. PubMed ID: 26363005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairments in Blood Pressure Regulation and Cardiac Baroreceptor Sensitivity Among Patients With Heart Failure Supported With Continuous-Flow Left Ventricular Assist Devices.
    Sailer C; Edelmann H; Buchanan C; Giro P; Babcock M; Swanson C; Spotts M; Schulte M; Pratt-Cordova A; Coe G; Beindorff M; Page RL; Ambardekar AV; Pal JD; Kohrt W; Wolfel E; Lawley JS; Tarumi T; Cornwell WK
    Circ Heart Fail; 2021 Jan; 14(1):e007448. PubMed ID: 33464953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity, venous capacitance, and venous compliance in heart failure with preserved ejection fraction.
    Sorimachi H; Burkhoff D; Verbrugge FH; Omote K; Obokata M; Reddy YNV; Takahashi N; Sunagawa K; Borlaug BA
    Eur J Heart Fail; 2021 Oct; 23(10):1648-1658. PubMed ID: 34053158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE-HF trial roll-in cohort.
    Fudim M; Fail PS; Litwin SE; Shaburishvili T; Goyal P; Hummel SL; Borlaug BA; Mohan RC; Patel RB; Mitter SS; Klein L; Rocha-Singh K; Patel MR; Reddy VY; Burkhoff D; Shah SJ
    Eur J Heart Fail; 2022 Aug; 24(8):1410-1414. PubMed ID: 35598154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure.
    Andersen MJ; Olson TP; Melenovsky V; Kane GC; Borlaug BA
    Circ Heart Fail; 2015 Jan; 8(1):41-8. PubMed ID: 25342738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-Year Committed Exercise Training Reverses Abnormal Left Ventricular Myocardial Stiffness in Patients With Stage B Heart Failure With Preserved Ejection Fraction.
    Hieda M; Sarma S; Hearon CM; MacNamara JP; Dias KA; Samels M; Palmer D; Livingston S; Morris M; Levine BD
    Circulation; 2021 Sep; 144(12):934-946. PubMed ID: 34543068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The β-Adrenergic Agonist Albuterol Improves Pulmonary Vascular Reserve in Heart Failure With Preserved Ejection Fraction.
    Reddy YNV; Obokata M; Koepp KE; Egbe AC; Wiley B; Borlaug BA
    Circ Res; 2019 Jan; 124(2):306-314. PubMed ID: 30582447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.